Theriva Biologics, Inc. (TOVX)
0.2497
0.00 (0.00%)
USD |
NYAM |
Aug 31, 11:18
Theriva Biologics Free Cash Flow : -12.76M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.76M |
| March 31, 2026 | -14.40M |
| December 31, 2025 | -16.70M |
| September 30, 2025 | -18.51M |
| June 30, 2025 | -18.09M |
| March 31, 2025 | -16.81M |
| December 31, 2024 | -16.94M |
| September 30, 2024 | -18.84M |
| June 30, 2024 | -18.01M |
| March 31, 2024 | -18.46M |
| December 31, 2023 | -19.20M |
| September 30, 2023 | -18.06M |
| June 30, 2023 | -19.44M |
| March 31, 2023 | -19.91M |
| December 31, 2022 | -19.20M |
| September 30, 2022 | -18.55M |
| June 30, 2022 | -16.24M |
| March 31, 2022 | -14.46M |
| December 31, 2021 | -12.90M |
| September 30, 2021 | -11.23M |
| June 30, 2021 | -11.13M |
| March 31, 2021 | -10.56M |
| December 31, 2020 | -12.18M |
| September 30, 2020 | -12.64M |
| June 30, 2020 | -13.65M |
| Date | Value |
|---|---|
| March 31, 2020 | -14.61M |
| December 31, 2019 | -13.87M |
| September 30, 2019 | -13.56M |
| June 30, 2019 | -14.10M |
| March 31, 2019 | -15.43M |
| December 31, 2018 | -17.29M |
| September 30, 2018 | -17.92M |
| June 30, 2018 | -19.04M |
| March 31, 2018 | -20.48M |
| December 31, 2017 | -20.42M |
| September 30, 2017 | -27.24M |
| June 30, 2017 | -28.65M |
| March 31, 2017 | -28.77M |
| December 31, 2016 | -28.47M |
| September 30, 2016 | -28.73M |
| June 30, 2016 | -38.20M |
| March 31, 2016 | -39.63M |
| December 31, 2015 | -39.39M |
| September 30, 2015 | -33.16M |
| June 30, 2015 | -22.11M |
| March 31, 2015 | -18.13M |
| December 31, 2014 | -16.13M |
| September 30, 2014 | -14.06M |
| June 30, 2014 | -11.23M |
| March 31, 2014 | -9.564M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Nkarta, Inc. | -93.90M |
| Unicycive Therapeutics, Inc. | -27.85M |
| OnKure Therapeutics, Inc. | -47.86M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.085M |
| Cash from Investing (Quarterly) | -0.003M |
| Cash from Financing (Quarterly) | -0.014M |
| Free Cash Flow Per Share (Quarterly) | -0.0673 |
| Free Cash Flow to Equity (Quarterly) | -2.948M |
| Free Cash Flow to Firm (Quarterly) | -3.088M |
| Free Cash Flow Yield | -154.5% |